Ref: PR Newswire, Financial Times, Bloomberg, Yahoo!Finance, The Wall Street Journal, The New York Times, ABC News, Otsuka) December 2nd, 2014 By: Matthew Dennis Otsuka announced Tuesday a definitive agreement to acquire Avanir Pharmaceuticals for $17.00 per share in cash, or approximately $3.5 billion, expanding its presence in neurologic diseases. The transaction, which has been [...]